Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Lexaria Bioscience Corp. (LEXX) had Receiveable Turnover of 3.01 for the most recently reported fiscal year, ending 2024-08-31.
| Income Statement Financials | |
$0.46M |
|
$-5.80M |
|
$0.00M |
|
$0.46M |
|
$6.22M |
|
$-5.75M |
|
$-0.06M |
|
$-5.81M |
|
$-5.74M |
|
$-5.81M |
|
$-5.81M |
|
$-5.81M |
|
$-5.74M |
|
$-5.75M |
|
$-5.68M |
|
12.38M |
|
12.38M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$7.90M |
|
$0.25M |
|
$0.97M |
|
$8.87M |
|
$1.10M |
|
-- |
|
$0.11M |
|
$1.21M |
|
$7.66M |
|
$7.14M |
|
$7.66M |
|
15.81M |
|
| Cash Flow Statement Financials | |
$-4.96M |
|
$-0.19M |
|
$10.32M |
|
$1.35M |
|
$6.50M |
|
$5.15M |
|
$0.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.96% |
|
-1239.16% |
|
-1239.16% |
|
-1222.75% |
|
-1251.12% |
|
-1248.25% |
|
$-5.00M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
|
Receiveable Turnover |
3.01 |
121.44 |
|
-75.84% |
|
-81.33% |
|
-65.50% |
|
-75.84% |
|
$0.48 |
|
$-0.40 |
|
$-0.40 |
|